Ozempic, Wegovy among drugs subject to Medicare price controls
1. Medicare will impose price controls on 15 prescription drugs in 2027. 2. Novo Nordisk's diabetes drugs Wegovy and Ozempic are included in this list. 3. Price control aims to reduce costs for Medicare Part D beneficiaries. 4. Drugmakers criticize the process, fearing negative impacts on innovation and access. 5. A coalition of over 40 groups is urging Congress to repeal the pricing scheme.